drugset / Trial / NCT00650364
Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan midodrine HCl 5 mg tablets to Roberts ProAmatine® 5 mg tablets following a single, oral 5 mg (1 x 5 mg) dose administration under fasting conditions.
Timeline
- Start
- 2002-08
- Primary completion
- 2002-08
- Completion
- 2002-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midodrine | Small molecule | 5 mg | Oral |
Indications
No indication recorded.